Effect of implementing an acute myocardial infarction guideline on quality indicators
Insights
Implementing an acute myocardial infarction clinical practice guideline improved adherence to quality care indicators. This study shows increased aspirin and beta-blocker use, contributing to better patient outcomes.
Area of Science:
- Cardiology
- Healthcare Quality Improvement
- Clinical Practice Guidelines
Background:
- Acute myocardial infarction (AMI) management requires adherence to evidence-based protocols.
- Clinical practice guidelines aim to standardize and improve care for AMI patients.
- Evaluating guideline implementation is crucial for assessing its impact on quality of care.
Purpose of the Study:
- To assess compliance rates with quality of care indicators following the introduction of an AMI clinical practice guideline.
- To compare patient outcomes before and after guideline implementation.
Main Methods:
- A quasi-experimental study comparing 1,431 AMI patients post-guideline implementation (March 2005-December 2012) with 306 pre-implementation patients.
- Key indicators: aspirin and beta-blocker prescription rates, door-to-balloon time, length of hospital stay, and in-hospital mortality.
- Statistical analysis to compare outcomes between the two periods.
Main Results:
- Significant increases in aspirin prescription on admission (99.6% vs. 95.8%) and discharge (99.1% vs. 95.8%), and beta-blocker prescription on discharge (95.9% vs. 81.7%) post-implementation (p<0.001 for all).
- Door-to-balloon time and length of hospital stay showed no significant difference.
- In-hospital mortality decreased significantly in the later period post-implementation (5.3% from 2009-2012) compared to before (7.6%) (p=0.04).
Conclusions:
- Implementation of an AMI clinical practice guideline effectively improved adherence to key quality of care indicators.
- The guideline's impact on improving medication adherence suggests a positive influence on patient care.
- Further evaluation is warranted to explore the sustained impact on clinical outcomes and cost-effectiveness.
Objective:
To evaluate the compliance rates to quality of care indicators along the implementation of an acute myocardial infarction clinical practice guideline.
Methods:
A clinical guideline for acute myocardial infarction was introduced on March 1st, 2005. Patients admitted for acute myocardial infarction from March 1st, 2005 to December 31st, 2012 (n=1,431) were compared to patients admitted for acute myocardial infarction before the implementation of the protocol (n=306). Compliance rates to quality of care indicators (ASA prescription on hospital admission and discharge, betablockers on discharge and door-to-balloon time) as well as the length of hospital stay and in-hospital mortality were compared before and after the implementation of the clinical guideline.
Results:
The rates of ASA prescription on admission, on discharge and of betablockers were higher after guideline implementation: 99.6% versus 95.8% (p<0.001); 99.1% versus 95.8% (p<0.001); and 95.9% versus 81.7% (p<0.001), respectively. ASA prescription rate increased over time, reaching 100% from 2009 to 2012. Door-to-balloon time after versus before implementation was of 86(32) minutes versus 93(51) (p=0.20). The length of hospital stay after the implementation versus before was of 6(6) days versus 6(4) days (p=0.34). In-hospital mortality was 7.6% (before the implementation), 8.7% between 2005 and 2008, and 5.3% between 2009 and 2012, (p=0.04).
Conclusion:
The implementation of an acute myocardial infarction clinical practice guideline was associated with an increase in compliance to quality of care indicators.
Related Concept Videos
01:20Angina V: Nursing Management
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Acute Coronary Syndrome V: Nursing Management
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Acute Coronary Syndrome I: Introduction